Cover
Cover | Aug. 18, 2022 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | On August 22, 2022, Precigen, Inc., a Virginia corporation (the “Company”), filed a Current Report on Form 8-K (the “Initial Form 8-K”) reporting the completion of the sale of 100% of the issued and outstanding membership interests of Trans Ova Genetics, L.C., an Iowa limited liability company (“Trans Ova”), to Spring Bidco LLC, a Delaware limited liability company (“Buyer”), pursuant to the terms of that certain Membership Interest Purchase Agreement, dated July 1, 2022, by and among the Company, Trans Ova and Buyer (the “Transaction”). |
Document Period End Date | Aug. 18, 2022 |
Entity File Number | 001-36042 |
Entity Registrant Name | Precigen, Inc. |
Entity Central Index Key | 0001356090 |
Entity Tax Identification Number | 26-0084895 |
Entity Incorporation, State or Country Code | VA |
Entity Address, Address Line One | 20374 Seneca Meadows Parkway |
Entity Address, City or Town | Germantown |
Entity Address, State or Province | MD |
Entity Address, Postal Zip Code | 20876 |
City Area Code | 301 |
Local Phone Number | 556-9900 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, No Par Value |
Trading Symbol | PGEN |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |